A DCI research team has found a new way to identify diverse CRISPR RNA variants that can specifically home in on challenging areas of DNA to target for editing.
DCI director Michael B. Kastan, MD, PhD, announced a planned reconfiguration of DCI’s NCI-Designated Research Programs and welcomed new research leaders.